17 Comments
 

Lmao intern, pjt doesn't even break into top 3 eb's in London for m&a deal flow. I just gave them a high ranking due to their rx dominance in Europe. 

 
Most Helpful

1 - Lazard (combination of exits, reputation, headcount and deal flow) 

2 - Rothschild (very strong in the region but a big portion of their work is MM) 

3 - CVC, PJT, EVE (Top compensation and exits but their business in London is far from what they are in the US) 

4 - PWP (Don't know them very well, but I have not heard good things about their culture, very German and French) 

5 - Moelis (avoid, they are very week in M&A in EMEA, most of their work is just US inbound opportunities) 

EB market share in London is much smaller than what it is in the US - in terms of deal exposure and buy side exits, I would take any top BB over EB (except for Lazard and maybe Rothschild) 

 

Somewhat agree with this list, but probably would promote pjt and evr based on recent exits. Also agree with the bb notion but I can also speak in the perspective off an an2 with a lot of mentees and still somewhat involved in my targets finance society. Yes, no one is choosing an eb in ldn over ms/gs(unless you're an rx enthusiast) however for the other top American bbs I have heard laz/roths/pjt/evr being taken instead over the last 2 years.

 

How are CVP and Evercore anywhere near PJT, and they have the exact same (maybe even worse) problem with deal flow like Moelis

 

Numquam iste saepe molestiae eveniet. Deserunt vel non quibusdam sed deserunt natus quis. Dolores eligendi ipsam praesentium maiores eaque. Provident quia itaque possimus unde sint. Eum necessitatibus odio doloremque repellat exercitationem ut. Rerum quaerat explicabo dicta.

Ipsum dolorum perspiciatis sit. Cum reprehenderit quod perspiciatis alias rerum voluptatem. Sed non deserunt corrupti est est aspernatur nesciunt. Et non ut consectetur quisquam quod. Ad ex quaerat suscipit error assumenda dolores.

Et animi accusantium quas. Quae amet distinctio sint sed. Voluptatem est neque sit. Laborum laboriosam quo molestiae.

Doloribus ea natus omnis repellendus non fuga. Sint labore dignissimos et temporibus id. Non facere et ducimus velit iste facilis facere. Beatae harum neque aperiam ut sed ratione omnis facere. Aut deleniti qui necessitatibus. Aut quia omnis a odio.

Career Advancement Opportunities

August 2026 Investment Banking

  • Evercore 01 99.4%
  • Moelis & Company 01 98.9%
  • JPMorgan 01 98.3%
  • Morgan Stanley 08 97.8%
  • Goldman Sachs 02 97.2%

Overall Employee Satisfaction

August 2026 Investment Banking

  • Moelis & Company No 99.4%
  • Evercore No 98.9%
  • Morgan Stanley 01 98.3%
  • Banco Santander 02 97.8%
  • BMO Capital Markets 12 97.2%

Professional Growth Opportunities

August 2026 Investment Banking

  • Evercore 01 99.4%
  • Moelis & Company 01 98.9%
  • Morgan Stanley 06 98.3%
  • Goldman Sachs 01 97.8%
  • JPMorgan 01 97.2%

Total Avg Compensation

August 2026 Investment Banking

  • Vice President (16) $429
  • Associates (48) $259
  • 3rd+ Year Analyst (8) $210
  • 2nd Year Analyst (25) $178
  • Intern/Summer Associate (14) $159
  • 1st Year Analyst (83) $151
  • Intern/Summer Analyst (75) $101
notes
16 IB Interviews Notes

“... there’s no excuse to not take advantage of the resources out there available to you. Best value for your $ are the...”

Leaderboard

1
redever's picture
redever
99.2
2
BankonBanking's picture
BankonBanking
99.0
3
kanon's picture
kanon
99.0
4
Secyh62's picture
Secyh62
99.0
5
CompBanker's picture
CompBanker
98.9
6
GameTheory's picture
GameTheory
98.9
7
dosk17's picture
dosk17
98.9
8
Betsy Massar's picture
Betsy Massar
98.9
9
DrApeman's picture
DrApeman
98.9
10
bolo up's picture
bolo up
98.8
success
From 10 rejections to 1 dream investment banking internship

“... I believe it was the single biggest reason why I ended up with an offer...”